title: Daclatasvir: a promising triple therapy for children with chronic hepatitis C.
authors.forename: Anna
authors.initials: A
authors.lastname: Alisi
authors.forename: Claudia
authors.initials: C
authors.lastname: Della Corte
authors.forename: Donatella
authors.initials: D
authors.lastname: Comparcola
authors.forename: Maria Rita
authors.initials: MR
authors.lastname: Sartorelli
authors.forename: Valerio
authors.initials: V
authors.lastname: Nobili
mesh_terms: D000293:Adolescent; D002219:Carbamates; D002648:Child; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D024882:Drug Resistance, Viral; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011759:Pyrrolidines; D016032:Randomized Controlled Trials as Topic; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D014633:Valine; C549273:daclatasvir